asdf098

$BMY bouncing off long-term support (4/5)

做多
NYSE:BMY   Bristol-Myers Squibb Company
Conviction: 4/5
might be better to buy when the stock goes over 1998 resistance


General Thesis
  • bouncing off of multi-cycle support (since 1974)
  • Weekly RSI showing sliiight bullish divergence

Growth
  • Margins quite low compared to own history
  • low growth

Value
  • very cheap
    Fundamentals
    low debt/asset ratio and plenty of cash to deal with short term debts

    Potential Risks
  • expensive market...
  • long-term resistance around 76 since 1998

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。